# Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis

> **NCT05276895** · NA · SUSPENDED · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DIETARY_SUPPLEMENT:** Quercetin and Fisetin tab.
- **DIETARY_SUPPLEMENT:** Quercetin Cap/Tab,Fisetin Cap/tab and Glycyrrhizin capsules
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05276895
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** unavailability of drugs
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05276895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05276895, "Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05276895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*